BioNovum

Bio-Novum offers a comprehensive portfolio of rapid diagnostic tests covering infectious diseases, tropical diseases, cardiac markers, tumor markers, pregnancy testing, drugs of abuse screening, and specialized multi-parameter panels. These rapid, easy-to-use lateral-flow tests support clinical diagnostics, point-of-care testing, and occupational or forensic screening, providing fast and cost-effective results across a wide range of medical and public-health applications.

Please Log In to access Additional Details and documents ..

• Covid-19 testing: Rapid antigen tests for SARS-CoV-2 detection designed for quick point-of-care screening.

• Pregnancy tests: Rapid urine hCG tests for early and reliable pregnancy detection.

• Tumor markers: Rapid tests for markers such as FOB (fecal occult blood) and calprotectin to support gastrointestinal and inflammatory diagnostics.

• Cardiac markers: Point-of-care tests for cardiac indicators such as cTnI (troponin I).

• Infectious disease tests: A broad range of tests covering respiratory, gastrointestinal, and bacterial infections, including influenza A/B, syphilis, H. pylori (antigen and antibody), Clostridium difficile (GDH and toxins), norovirus, Giardia lamblia, rotavirus/adenovirus, RSV, MONO, and strep A/B.

• Tropical disease tests: Rapid tests for malaria, Chagas disease, dengue (including NS1 and combo formats), chikungunya, and Zika (including NS1 and combined IgG/IgM/NS1 panels).

• Drugs of abuse tests: A wide panel of single-parameter and multi-parameter drug tests covering amphetamines, barbiturates, benzodiazepines, buprenorphine, cocaine, ecstasy/MDMA, fentanyl, marijuana/THC, mephedrone, methadone, methamphetamine, morphine, PCP, synthetic cannabinoids (K2), tramadol, tricyclic antidepressants, and others.

Multi-panel drug screening tests: Multiplex tests including 5-panel, 6-panel (oral fluids), 10-panel, and advanced multi-drug panels targeting combinations of substances such as OXY, MDPV, K2, LSD, MEP, and CAT.